Coty is a global beauty company that sells fragrances, cosmetics, and skincare products across 125 countries. It generated $5.89 billion in revenue last year, but its growth has stalled as its mass-market makeup business faces stiff competition. In 2025, the company reported a net loss of $370 million, largely driven by significant non-cash charges that reflected the declining value of its older consumer brands.
The investment thesis on Coty is that its high-end prestige fragrance business is valuable enough to carry the weight of its struggling mass-market cosmetics brands while it pays down debt. Coty owns the licenses for luxury names like Burberry and Hugo Boss, which are still growing and command high prices. If management can successfully shrink the mass-market division and focus solely on these luxury licenses, the business becomes more profitable and less complex.
We think Coty is a business with strong luxury assets but a broken balance sheet that leaves almost no room for error. The high debt and weak performance in mass-market makeup make this a difficult stock to own until the debt levels drop significantly.
What does it do?
Coty is a mature business that earns money by designing, manufacturing, and selling beauty products through two distinct divisions. The Prestige division sells high-end fragrances and skincare under licensed luxury brands like Gucci and Burberry, while the Consumer Beauty division sells mass-market makeup and body care brands like CoverGirl and Sally Hansen. Coty earns a margin on every bottle or tube sold through department stores, drugstores, and online retailers. Customers keep paying because fragrance and cosmetics are high-frequency, emotional purchases where brand loyalty is often tied to celebrity or designer associations.
Where does revenue come from?
Most of Coty's revenue now comes from its Prestige division, which accounts for 65% of total sales. The Prestige segment focus on luxury fragrances is the company's primary profit engine. The remaining 35% comes from Consumer Beauty, which has been shrinking as mass-market shoppers shift toward newer, digitally native brands. Geographically, EMEA is the largest market, followed by the Americas and Asia Pacific.
Revenue Breakdown
Revenue by Geography
Who are its customers?
Coty serves millions of individual consumers globally through a network of prestige retailers, department stores, and mass-market drugstores. While it does not disclose a specific active user count like a software company, its scale is defined by its presence in 125 countries. In the most recent quarter, the Prestige division generated $830.9 million in sales, while the Consumer Beauty division brought in $450.7 million. The company is increasingly focused on the "ultra-premium" customer, launching high-end skincare brands like Orveda and expanding its luxury boutique footprint in major cities like New York and Paris.
What gives it staying power?
Coty's staying power comes from its exclusive, long-term licenses with global fashion houses that would be nearly impossible for a newcomer to replicate. These multi-year contracts for names like Calvin Klein and Marc Jacobs provide a stable foundation for the fragrance business that competitors cannot easily take.
Where is it headed?
Coty is doubling down on luxury fragrances and high-end skincare while aggressively cutting costs in its mass-market business. Management is implementing a strategy called "Coty.Curated" to reduce the number of small, unprofitable product launches. If this works, it will turn Coty into a leaner, more profitable luxury-focused company that can finally pay off its heavy debts.
Verdict: Revenue is currently shrinking as mass-market brands lose ground. Total revenue fell to $1.28 billion in the most recent quarter, a 1% decline that would have been a 7% drop if not for favorable currency moves.
Verdict: Free cash flow is positive but is being used primarily to manage a heavy debt load. The company generated $276 million in free cash flow over the first nine months of the fiscal year, though high interest costs continue to limit its ability to reinvest.
Verdict: The balance sheet is heavily burdened by more than $3.2 billion in total debt. This high leverage ratio of 3.4x net debt to adjusted EBITDA leaves the company vulnerable to any further slowdown in consumer spending.
Coty is a financially fragile business with valuable luxury assets that are currently being overshadowed by high debt and a declining mass-market division.
The Prestige fragrance business remains a bright spot, holding steady at $830.9 million in sales even in a difficult global market. This division accounts for 65% of revenue and is the only part of the company currently showing resilience through luxury brand licenses.
Watch the Consumer Beauty division, which saw revenue drop 10% on a like-for-like basis last quarter. If this segment continues to shrink, it will force more non-cash write-downs and prevent the company from paying down its debt as planned.
The global beauty market is a massive $500B+ industry growing at roughly 4% annually, on track to reach $600B by 2030. Pricing power is generally structural in the luxury fragrance segment but has become a race to the bottom in mass-market cosmetics. Coty is a major player in fragrances due to its licensed brands, but it is currently a struggling challenger in the cosmetics space, where it is losing shelf space to newer, more agile competitors.
The beauty industry is brutally competitive, with low barriers to entry for new, celebrity-backed brands that can go viral on social media. Established players face constant pressure to spend heavily on marketing just to keep their existing market share. This dynamic erodes long-term pricing power for any brand that isn't considered truly "luxury."
Coty's most dangerous threats are L'Oréal and Estée Lauder, who have far more cash to spend on advertising and acquisitions. L'Oréal's massive scale allows it to undercut Coty on manufacturing costs while outspending them on influencer marketing. Meanwhile, newer players like e.l.f. Beauty are using digital-first strategies to steal younger customers away from Coty's legacy brands like CoverGirl.
Coty is currently losing share in mass-market makeup, evidenced by the 10% decline in its Consumer Beauty division last quarter.
Coty’s primary protection comes from its exclusive, long-term brand licenses for luxury names like Gucci and Burberry. These licenses act as an intangible asset that prevents others from selling fragrances under these famous names. However, this protection only applies to the Prestige division and does not cover its mass-market makeup business.
The company's 3.8% ROIC and high debt load suggest that its competitive advantage is currently very weak. A real moat would produce returns well above the cost of debt, but Coty is currently earning less than it pays to borrow. These numbers are more consistent with a business in a difficult cycle than one with a durable advantage.
The moat is eroding as the value of mass-market brands declines, and the signal is the repeated impairment charges the company has taken.
Repeatedly missed sales growth targets in the Consumer Beauty division over several quarters.
Carrying $3.2B in debt while reporting net losses and taking large impairment charges.
Management has focused on debt reduction, but high debt remains a central risk.
Capital Allocation Track Record
Management quality is adequate, but they are currently operating with very little room for error due to the heavy debt inherited from previous leadership. Markus Strobel is currently serving as the interim CEO while the board looks for a permanent leader, which creates a period of strategic uncertainty. The team has made the right decision to focus on luxury and cut the number of "small" product launches, but they have yet to prove they can grow the mass-market makeup business again.
The primary risk is the leadership transition and the high level of dependence on maintaining expensive luxury licenses. If Coty were to lose a major license like Burberry or Gucci, the thesis for the entire company would break. There is also a governance concern regarding the high debt load, as the company’s survival depends on its ability to keep the trust of its lenders while it tries to fix its underlying business.
We expect revenue to grow from $5.7B in FY2026 to $6.1B in FY2031 (~1% CAGR), with EPS growing from $0.22 to $0.54 (~20% CAGR). Growth is driven by the continued shift toward the high-end prestige fragrance market and expansion into ultra-premium skincare. Profits improve as the company reduces its heavy debt load and shifts its sales mix toward higher-priced luxury products. EPS grows faster than revenue because profit margins are recovering from recent lows while interest costs decrease. Operating margin expected to reach ~12% by FY2031.
Luxury fragrance expansion into high-growth Asian markets. If Coty can successfully bring brands like Burberry to the Chinese middle class, it can offset slower growth in Europe.
High-margin skincare brands like Orveda reach critical scale. Successful skincare launches could double the profit margin of the overall business compared to cheaper cosmetics.
AI-driven marketing reduces costs across all owned brands. Using AI for content creation could save hundreds of millions in marketing production costs annually.
Loss of a major luxury license like Gucci or Burberry. Losing a top-tier license would instantly remove a massive portion of Coty's revenue and profit.
Continued market share loss in mass-market makeup to e.l.f.. If CoverGirl continues to shrink at double digits, the mass-market division will become a permanent drain on cash.
High debt prevents necessary investment in new product categories. With $3.2B in debt, Coty may not be able to afford the marketing needed to compete with L'Oréal.
Below is our estimate of current and future fair value, with detailed reasoning and assumptions. Fair value is a judgment, not a fact, and other analysts will likely land on different numbers. Use it as one data point in your research, and apply your own discretion in any investing decision.
We use a Forward P/E approach based on FY2027 earnings to value Coty. This framework fits best because Coty is currently in a transitional loss-making phase; using a forward-looking earnings base captures the return to profitability and the impact of the Gucci license windfall better than trailing metrics which are distorted by one-time restructuring charges and debt-swaps.
Our fair value of $4 is calculated by applying a 11.5x multiple to the FY2027 EPS estimate of $0.35. A 11.5x multiple sits at a significant discount to peers like Estée Lauder (22x) and Inter Parfums (19x), reflecting Coty's higher leverage and the upcoming loss of the Gucci license revenue. We use a FY2027 EPS of $0.35 instead of the deterministic engine's 5-year terminal value because the high debt load makes near-term cash application to deleveraging more relevant than long-term terminal projections.
Cross-checked with an EV/EBITDA valuation (10x EBITDA - Net Debt), we derive a fair value of $5.47, suggesting our $4 headline target is conservative. Applying a 10x multiple to TTM EBITDA of $812.4M yields an Enterprise Value of $8.12B; subtracting $3.3B in net debt leaves $4.82B in equity value, or $5.47 per share. The discrepancy exists because the market is currently pricing Coty at a distressed 5x EBITDA; a move to just 10x (still below the 12.3x historical average) would double the stock price.
We're assuming the $400 million payment from Kering is utilized entirely for debt reduction by the end of FY2027. This cash injection represents roughly 21% of Coty's current market capitalization and is the primary catalyst for reducing interest expenses, which have recently dragged the company into GAAP net losses despite strong gross margins.
We're assuming the Prestige division can maintain 65% of total revenue despite the early transition of the Gucci license. The "skincritization" of makeup and a deeper push into high-end fragrances like Hugo Boss and Burberry provide a large enough runway to fill the revenue gap if Coty successfully executes its "Fragrance 2.0" strategy focused on emotional wellness scents.
We're assuming the Consumer Beauty segment stabilizes at a -2% to -4% annual decline rather than a total collapse. Management’s "Coty.Curated" initiative is designed to harvest cash from mass-market brands like Rimmel and Sally Hansen; as long as these brands don't require massive capital injections to stay relevant, they remain useful for servicing the debt.
The primary risk is the $3.57 billion total debt load which restricts Coty's ability to reinvest in its remaining core brands. If high interest rates persist and the company fails to capture the $400 million Kering payment for effective deleveraging, the multiple would likely compress from 11x to 8x, knocking roughly $1.20 off our fair value and keeping the stock near all-time lows. Watch "Net Debt-to-EBITDA" for any move back toward 5.0x.
Bear case ($2): Consumer Beauty segment revenue declines exceed 8% annually as mass-market brands lose shelf space to private labels; or Net Debt-to-EBITDA leverage remains above 4.5x through 2027 due to higher-than-expected restructuring costs from the "Coty.Curated" pivot.
Bull case ($6): Prestige segment skincare launches achieve 15%+ market penetration in Asia Pacific, offsetting the loss of Gucci fragrance revenue; or Multiple expansion occurs as the company hits GAAP profitability, rerating Coty from a "distressed" 6x forward multiple to 15x.
Clearthesis wrote this report from 38 sources, including SEC filings, industry research, and recent news.
How did you like this thesis?
Your feedback helps us make reports better for you
© 2026 Clearthesis.ai · Report generated on July 9, 2026
This is an AI-generated analysis for informational purposes only and does not constitute financial advice. Data and analysis may not reflect recent developments if viewed significantly after the generation date. Always conduct your own due diligence before making any investment decisions.